NCT01666535View on ClinicalTrials.gov

Infliximab IBD Influenza Vaccine Study

NACompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

August 31, 2013

Conditions
Inflammatory Bowel Disease
Interventions
BIOLOGICAL

Influenza vaccination

Trial Locations (1)

T3B 6A8

University of Calgary, Calgary

All Listed Sponsors
collaborator

Janssen Inc.

INDUSTRY

lead

University of Calgary

OTHER

NCT01666535 - Infliximab IBD Influenza Vaccine Study | Biotech Hunter | Biotech Hunter